The androgen/androgen receptor (AR) axis plays a vital role in the pathogenesis of PCa, thereby androgen deprivation therapy (ADT) remains the first choice for this disease (Di Zazzo et al., 2019). Here, AR is linked to posterior cortical atrophy.